Replimune Group Earnings
NASDAQ: REPLHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
19.07-0.16 (-0.83%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Replimune Group earnings summary
In its most recent report on Oct 28, 2026 (Sep/2026), REPL posted EPS of $-0.54 versus the $-0.70 consensus estimate, a positive surprise of 22.9%. Across the last 16 reports, REPL shares moved an average of 7.8% (in either direction) in the first trading session after results, rising 8 times and falling 8 times.
Summary generated from market data by MetaCap's automated system. Methodology
REPL earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Oct 28, 2026 | $-0.70 | $-0.54 | +22.9% | +22.8% |
| Aug 14, 2026 | — | $-0.72 | — | -1.3% |
| Jun 29, 2026 | — | $-0.76 | — | -5.1% |
| Feb 3, 2026 | — | $-0.77 | — | +2.8% |
| Nov 6, 2025 | — | $-0.90 | — | +8.2% |
| Aug 7, 2025 | — | $-0.95 | — | +5.1% |
| May 22, 2025 | — | $-0.82 | — | +7.5% |
| Feb 12, 2025 | — | $-0.79 | — | -0.9% |
| Nov 12, 2024 | — | $-0.68 | — | +38.2% |
| Aug 8, 2024 | — | $-0.78 | — | +5.5% |
| May 16, 2024 | — | $-0.82 | — | -18.9% |
| Feb 8, 2024 | — | $-0.77 | — | -0.4% |
| Nov 7, 2023 | — | $-0.90 | — | -6.4% |
| Aug 3, 2023 | — | $-0.75 | — | +0.8% |
| May 18, 2023 | — | $-0.73 | — | -0.5% |
| Feb 9, 2023 | — | $-0.69 | — | -0.4% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.